Latest Cardiovascular diseases Stories
Mount Sinai’s Valentin Fuster, MD, PhD, Joins Forces with Other Leading Global Cardiovascular Experts to Provide a Road Map for Reducing the Growing Worldwide Epidemic of Cardiovascular Diseases
The rate of hospitalisation for the most serious type of heart attack, ST-segment elevation myocardial infarction (STEMI), more than quadrupled in China between 2001 and 2011.
In an analysis that included data from 16 trials performed over the last 45 years, among patients with pulmonary embolism, receipt of therapy to dissolve the blood clot (thrombolysis) was associated with lower rates of death, but increased risks of major bleeding and intracranial hemorrhage.
DALLAS, June 13, 2014 /PRNewswire/ -- MarketReportsChina.com adds "Research on China Cardiovascular Drugs Industry, 2014-2018" market intelligence report of 85 pages to
A Great Debate at EuroPCR 2014 saw experts discussing the role of the two most valuable strategies to save the lives of ST-segment Elevation Myocardial Infarction (STEMI) patients: primary percutaneous coronary intervention (PCI) and thrombolysis.
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed an ultrasound device that could help identify arterial plaque that is at high risk of breaking off and causing heart attack or stroke.
Imaging of the coronary arteries with computed tomography (CT) angiography provides an accurate assessment of arterial plaque and could have a dramatic impact on the management of diabetic patients who face a high risk of heart attacks and other cardiovascular events.
SAN CLEMENTE, Calif., April 14, 2014 /PRNewswire/ -- ROX Medical today announced it has completed enrollment for CONTROL-HTN trial, an international multi center, prospective, randomized, controlled,
The global market for peripheral vascular surgical devices was valued at $5.8 billion in 2012 and at $6.2 billion for 2013.
Noninvasive imaging of carotid artery plaque with MRI can accurately predict future cardiovascular events like strokes and heart attacks in people without a history of cardiovascular disease.
- A person in a secondary role, specifically the second most important character (after the protagonist).